Trulieve Cannabis is trading at $11.90, down 4.11%, with no clear company-specific catalyst identified for the September 29 after-hours drop.
- Trulieve announced an exclusive licensing deal for Alien Labs and Connected products in Florida and Texas; coverage does not link it to the decline.
- No cannabis-sector explanation for the drop was found.
- Major indices were mixed, and the available evidence does not establish a broader-market cause.